You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,962,151


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,962,151
Title: Inhalation nebulizer
Abstract:An inhalation nebulizer (1) includes an aerosol generator (2) that has a diaphragm (22) vibrated by a vibration generator (23). The inhalation nebulizer (1) includes a liquid storage container (21) that is in fluid contact with the diaphragm (22). A liquid contained in the storage container (21) is atomized into a mixing chamber (3) through openings in the diaphragm and can subsequently be inhaled by a patient.
Inventor(s): Knoch; Martin (Berg, DE), Keller; Manfred (Bad Krozingen, DE), Stangl; Roland (Moosburg, DE), Gallem; Thomas (Munich, DE), Liening-Ewert; Rainer (Alfausen, DE), Urich; Markus (Munich, DE)
Assignee: Pari GmbH Spezialisten fur effektive Inhalation (Starnberg, DE)
Application Number:10/129,498
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery; Device; Dosage form;
Patent landscape, scope, and claims:

United States Patent 6,962,151: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 6,962,151, titled "Inhalation Nebulizer," is a significant innovation in the field of medical devices, particularly for inhalation therapy. This patent, granted to an inventor for an improved inhalation nebulizer, has several key aspects that define its scope, claims, and position within the broader patent landscape.

Scope of the Patent

Purpose and Functionality

The patent describes an inhalation nebulizer designed to deliver therapeutically effective amounts of pharmaceuticals to a patient's respiratory tract. The device forms an aerosol from liquid pharmaceuticals, ensuring that the particles are of a size that can be easily inhaled[1][5].

Key Components

The nebulizer includes an aerosol generator with a diaphragm that is vibrated by a vibration generator. This mechanism is crucial for creating the aerosol from the liquid pharmaceuticals. The design aims to minimize aerosol losses, enhancing the efficiency of the inhalation therapy[1][5].

Claims of the Patent

Independent and Dependent Claims

The patent includes several claims that define the scope of the invention. These claims can be categorized into independent and dependent claims.

  • Independent Claims: These claims stand alone and define the broadest scope of the invention. For example, Claim 1 might describe the overall structure and function of the inhalation nebulizer, including the aerosol generator and the vibration mechanism[1].
  • Dependent Claims: These claims build upon the independent claims and provide additional details or limitations. For instance, a dependent claim might specify the material of the diaphragm or the frequency of the vibration generator[1].

Claim Construction

The claims are constructed to ensure that the invention is clearly defined and distinguishable from prior art. This involves detailed descriptions of the components, their interactions, and the specific improvements over existing nebulizers[1].

Patent Landscape

Prior Art

The patent landscape for inhalation nebulizers includes various prior art references, such as EP 0 170 715 A1, which uses a compressed gas flow to form an aerosol. The US6962151B1 patent differentiates itself by using a vibration generator to vibrate a diaphragm, which is more efficient and reduces aerosol losses[1].

Related Patents and Applications

Other patents and patent applications in the field of inhalation nebulizers often focus on different aspects such as aerosol generation methods, device portability, and user interface improvements. The US6962151B1 patent is part of a broader ecosystem that includes innovations from various manufacturers and researchers[4].

Classification and International Context

International Classification

The patent is classified under A61M15/0001, which pertains to details of inhalators and their constructional features. This classification helps in identifying similar patents and applications globally[1].

Global Patent System

The patent is part of the global patent system, and its family can be traced through services like the Global Dossier, which provides access to file histories of related applications from participating IP Offices. This facilitates a comprehensive view of the patent's international status and related applications[4].

Legal and Administrative Aspects

Patent Infringement Claims

In the event of alleged patent infringement, the claimant must follow specific procedures outlined by the US Department of Defense and the USPTO. This includes providing detailed allegations, requests for compensation, and identification of the alleged infringing item or process[2].

Patent Search and Analysis Tools

Tools like the Patent Public Search, Global Dossier, and Patent Examination Data System (PEDS) are essential for conducting thorough searches and analyses of patents. These tools help in understanding the patent's position within the broader landscape and identifying potential infringement issues[4].

Economic and Research Implications

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents, including those related to medical devices like inhalation nebulizers. This dataset helps in analyzing trends and scope measurements of patents, which can be crucial for economic and research purposes[3].

Market Impact

The invention described in US6962151B1 has the potential to significantly impact the market for inhalation nebulizers by offering a more efficient and effective device. This can lead to improved patient outcomes and increased market share for the patent holder.

Key Takeaways

  • Efficient Aerosol Generation: The patent describes an inhalation nebulizer that uses a vibration generator to create aerosols, minimizing losses and enhancing therapy efficiency.
  • Detailed Claims: The patent includes both independent and dependent claims that clearly define the invention and its improvements over prior art.
  • Global Context: The patent is part of the global patent system and can be analyzed using various international patent search tools.
  • Legal Considerations: Alleged infringement claims must follow specific procedures, and tools are available for thorough patent searches and analyses.
  • Market Impact: The invention has the potential to improve patient outcomes and gain significant market share.

FAQs

What is the primary innovation of US6962151B1?

The primary innovation is the use of a vibration generator to vibrate a diaphragm in the aerosol generator, which improves the efficiency of aerosol formation and reduces losses.

How does this patent differentiate itself from prior art?

It differentiates itself by using a vibration mechanism instead of compressed gas flow, as seen in prior art like EP 0 170 715 A1.

What are the key components of the inhalation nebulizer described in the patent?

The key components include an aerosol generator with a diaphragm and a vibration generator.

How can one search for related patents and applications?

One can use tools like the Patent Public Search, Global Dossier, and Patent Examination Data System (PEDS) to search for related patents and applications.

What are the implications of this patent for the market?

The patent has the potential to improve patient outcomes and increase market share for the patent holder due to its more efficient and effective aerosol generation method.

Sources

  1. US6962151B1 - Inhalation nebulizer - Google Patents
  2. Requirements for filing an administrative claim for patent infringement - Acquisition.gov
  3. Patent Claims Research Dataset - USPTO
  4. Search for patents - USPTO
  5. US-20060054166-A1 - Inhalation Nebulizer - Unified Patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,962,151

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,962,151

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany199 53 317Nov 5, 1999
PCT Information
PCT FiledOctober 27, 2000PCT Application Number:PCT/US00/29541
PCT Publication Date:May 17, 2001PCT Publication Number: WO01/34232

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.